Cumberland Pharmaceuticals (CPIX) Cash from Investing Activities Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -53.63% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -55.36% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 34.35% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 33.61% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 15.92% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -2.45% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -36.76% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -170.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -170.99% |
| Mar 31, 2026 | 29.48% |
| Dec 31, 2025 | -68.64% |
| Sep 30, 2025 | -44.46% |
| Jun 30, 2025 | 54.06% |
| Mar 31, 2025 | 55.07% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | 55.39% |
| Jun 30, 2024 | 1.19% |
| Mar 31, 2024 | 43.25% |
| Dec 31, 2023 | 41.36% |
| Sep 30, 2023 | 47.81% |
| Jun 30, 2023 | 21.72% |
| Mar 31, 2023 | 32.65% |
| Dec 31, 2022 | -32.70% |
| Sep 30, 2022 | -53.88% |
| Jun 30, 2022 | 67.05% |
| Mar 31, 2022 | -98.81% |
| Dec 31, 2021 | 89.22% |
| Sep 30, 2021 | -26.50% |